Drug Type Small molecule drug |
Synonyms LEVONORDEFRIN/PROCAINE HYDROCHLORIDE/PROPOXYCAINE HYDROCHLORIDE, RAVOCAINE AND NOVOCAIN W/ NEO-COBEFRIN, Ravocaine And Novocain W/Levophed |
Mechanism Sodium channels blockers, α1A-AR agonists(Alpha-1a adrenergic receptor agonists), α1B-AR agonists(Alpha-1b adrenergic receptor agonists) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseWithdrawn |
First Approval Date US (19 Sep 1952) |
Regulation- |
Molecular FormulaC16H27ClN2O3 |
InChIKeyGITPCGSPKUQZTE-UHFFFAOYSA-N |
CAS Registry550-83-4 |